Literature DB >> 12032631

Structural changes in renal arterioles in Type I diabetic patients.

R Østerby1, A Hartmann, H-J Bangstad.   

Abstract

AIMS/HYPOTHESIS: We aimed to obtain data on arteriolar structure in a follow-up study of microalbuminuric diabetic patients.
METHODS: Kidney biopsies were obtained at baseline and after 8 years in 18 Type I (insulin-dependent) diabetic patients. Albumin excretion rate, blood pressure and HbA(1C) were measured regularly, and the glomerular filtration rate (GFR) was measured at the time of the kidney biopsy. The biopsy was embedded into plastic blocks and serially sectioned with 1 microm sections. In levels 25 microm apart, afferent and efferent arteriolar profiles were identified and digitised in the electron microscope. The extra-cellular matrix as volume fraction of the media was measured, and estimates of thickness of matrix, media, endothelium and lumen were obtained. Baseline and follow-up biopsies were studied concomitantly.
RESULTS: A large increase was seen in matrix volume fraction in afferent ( p = 0.0001) and in efferent arterioles ( p = 0.0004). Estimated thickness of media and matrix increased, whereas endothelial cell thickness decreased, over the 8 years. There was a correlation between the parameters of diabetic glomerulopathy and arteriolar parameters in the biopsies done at 8 years, basement membrane thickness compared with afferent matrix volume fraction: r = 0.74, p = 0.0005. Also aggravation of glomerulopathy and arteriolar structure over 8 years showed positive correlation. Arteriolar parameters correlated with the albumin excretion rate (AER) and inversely with GFR. CONCLUSION/
INTERPRETATION: The arteriolar accumulation of matrix parallels that taking place in glomeruli and shows association with functional parameters over 8 years in Type I diabetic patients with microalbuminuria. These changes are considered an important part of the structural lesions in the diabetic kidney underlying the development of diabetic nephropathy.

Entities:  

Mesh:

Year:  2002        PMID: 12032631     DOI: 10.1007/s00125-002-0780-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy.

Authors:  Akane Kizu; Damian Medici; Raghu Kalluri
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

2.  Case report: Infantile systemic hyalinosis: a dental perspective.

Authors:  D Olczak-Kowalczyk; E Krasuska-Slawinska; D Rokicki; M Pronicki
Journal:  Eur Arch Paediatr Dent       Date:  2011-08

Review 3.  Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant?

Authors:  K E White; S M Marshall; R W Bilous
Journal:  Diabetologia       Date:  2007-02-27       Impact factor: 10.122

4.  Abnormal angiogenesis in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Tomoki Kosugi; Masakazu Haneda; Christopher J Rivard; David A Long
Journal:  Diabetes       Date:  2009-07       Impact factor: 9.461

Review 5.  Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.

Authors:  Adviye Ergul; Mohammed Abdelsaid; Abdelrahman Y Fouda; Susan C Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

6.  Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy.

Authors:  E Hadler-Olsen; J-O Winberg; F P Reinholt; T Larsen; L Uhlin-Hansen; T Jenssen; E Berg; S O Kolset
Journal:  ISRN Endocrinol       Date:  2011-08-04

Review 7.  Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.

Authors:  Takahiko Nakagawa; Waichi Sato; Tomoki Kosugi; Richard J Johnson
Journal:  J Diabetes Res       Date:  2013-12-09       Impact factor: 4.011

8.  Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus.

Authors:  Shan Chen; Huiqing Li; Chun Zhang; Zhenqiong Li; Qiuyuan Wang; Jinting Guo; Changqing Luo; Yumei Wang
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

9.  Matrix metalloproteinases in subjects with type 1 diabetes.

Authors:  Sedegheh Gharagozlian; Katja Svennevig; Hans-Jacob Bangstad; Jan-Olof Winberg; Svein Olav Kolset
Journal:  BMC Clin Pathol       Date:  2009-09-16

10.  Promoting effects of the adipokine, apelin, on diabetic nephropathy.

Authors:  Bao-hai Zhang; Wenying Wang; Hongxia Wang; Jiming Yin; Xiang-jun Zeng
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.